UBISOFT ENTERTAINMENT (UBI.PA) Fundamental Analysis & Valuation

EPA:UBI • FR0000054470

Current stock price

4.859 EUR
-0.03 (-0.67%)
Last:

This UBI.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. UBI.PA Profitability Analysis

1.1 Basic Checks

  • UBI had negative earnings in the past year.
  • In the past year UBI had a positive cash flow from operations.
  • In multiple years UBI reported negative net income over the last 5 years.
  • In the past 5 years UBI always reported a positive cash flow from operatings.
UBI.PA Yearly Net Income VS EBIT VS OCF VS FCFUBI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

  • UBI has a Return On Assets of -1.71%. This is comparable to the rest of the industry: UBI outperforms 42.55% of its industry peers.
  • UBI has a Return On Equity (-4.71%) which is comparable to the rest of the industry.
  • UBI has a Return On Invested Capital of 2.04%. This is comparable to the rest of the industry: UBI outperforms 57.45% of its industry peers.
Industry RankSector Rank
ROA -1.71%
ROE -4.71%
ROIC 2.04%
ROA(3y)-3.63%
ROA(5y)-1.44%
ROE(3y)-11.29%
ROE(5y)-4.65%
ROIC(3y)N/A
ROIC(5y)N/A
UBI.PA Yearly ROA, ROE, ROICUBI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • UBI has a better Operating Margin (5.87%) than 63.83% of its industry peers.
  • UBI has a Gross Margin of 89.78%. This is in the better half of the industry: UBI outperforms 74.47% of its industry peers.
  • UBI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.87%
PM (TTM) N/A
GM 89.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y1.21%
UBI.PA Yearly Profit, Operating, Gross MarginsUBI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. UBI.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so UBI is destroying value.
  • UBI has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, UBI has more shares outstanding
  • Compared to 1 year ago, UBI has an improved debt to assets ratio.
UBI.PA Yearly Shares OutstandingUBI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
UBI.PA Yearly Total Debt VS Total AssetsUBI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

  • Based on the Altman-Z score of 0.98, we must say that UBI is in the distress zone and has some risk of bankruptcy.
  • UBI has a Altman-Z score (0.98) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of UBI is 2.65, which is a good value as it means it would take UBI, 2.65 years of fcf income to pay off all of its debts.
  • UBI's Debt to FCF ratio of 2.65 is fine compared to the rest of the industry. UBI outperforms 72.34% of its industry peers.
  • UBI has a Debt/Equity ratio of 1.11. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 1.11, UBI perfoms like the industry average, outperforming 42.55% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 2.65
Altman-Z 0.98
ROIC/WACC0.37
WACC5.56%
UBI.PA Yearly LT Debt VS Equity VS FCFUBI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 1.18 indicates that UBI should not have too much problems paying its short term obligations.
  • The Current ratio of UBI (1.18) is better than 70.21% of its industry peers.
  • UBI has a Quick Ratio of 1.17. This is a normal value and indicates that UBI is financially healthy and should not expect problems in meeting its short term obligations.
  • UBI's Quick ratio of 1.17 is fine compared to the rest of the industry. UBI outperforms 70.21% of its industry peers.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.17
UBI.PA Yearly Current Assets VS Current LiabilitesUBI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. UBI.PA Growth Analysis

3.1 Past

  • The earnings per share for UBI have decreased strongly by -207.14% in the last year.
  • The Revenue for UBI has decreased by -11.78% in the past year. This is quite bad
  • UBI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.56% yearly.
EPS 1Y (TTM)-207.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)-11.78%
Revenue growth 3Y-3.68%
Revenue growth 5Y3.56%
Sales Q2Q%2.41%

3.2 Future

  • UBI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.34% yearly.
  • The Revenue is expected to grow by 3.54% on average over the next years.
EPS Next Y-924.66%
EPS Next 2Y37.4%
EPS Next 3Y38.55%
EPS Next 5Y26.34%
Revenue Next Year-18.99%
Revenue Next 2Y-5.54%
Revenue Next 3Y-1.92%
Revenue Next 5Y3.54%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
UBI.PA Yearly Revenue VS EstimatesUBI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
UBI.PA Yearly EPS VS EstimatesUBI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 -2 -4

More info and screens

Find the best growth stocksShow best growing peers

3

4. UBI.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • UBI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for UBI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UBI.PA Price Earnings VS Forward Price EarningsUBI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60

4.2 Price Multiples

  • 78.72% of the companies in the same industry are more expensive than UBI, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of UBI indicates a rather cheap valuation: UBI is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 0.83
EV/EBITDA 3.52
UBI.PA Per share dataUBI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • UBI's earnings are expected to grow with 38.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.4%
EPS Next 3Y38.55%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. UBI.PA Dividend Analysis

5.1 Amount

  • UBI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

UBI.PA Fundamentals: All Metrics, Ratios and Statistics

UBISOFT ENTERTAINMENT

EPA:UBI (4/30/2026, 10:11:09 AM)

4.859

-0.03 (-0.67%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Industry Strength5.41
Industry Growth46.67
Earnings (Last)02-12
Earnings (Next)05-20
Inst Owners45.76%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap654.85M
Revenue(TTM)1.89B
Net Income(TTM)-73.60M
Analysts50.48
Price Target6.06 (24.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.84%
PT rev (3m)-33.39%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.37%
EPS NY rev (3m)-954.69%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.52%
Revenue NY rev (3m)-15.4%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.35
P/FCF 0.83
P/OCF 0.8
P/B 0.42
P/tB N/A
EV/EBITDA 3.52
EPS(TTM)-0.15
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)5.84
FCFY120.21%
OCF(TTM)6.08
OCFY125.11%
SpS13.99
BVpS11.6
TBVpS-6.37
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -1.71%
ROE -4.71%
ROCE 3.3%
ROIC 2.04%
ROICexc 2.18%
ROICexgc 9.5%
OM 5.87%
PM (TTM) N/A
GM 89.78%
FCFM 41.76%
ROA(3y)-3.63%
ROA(5y)-1.44%
ROE(3y)-11.29%
ROE(5y)-4.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y1.21%
F-Score3
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 2.65
Debt/EBITDA 2.4
Cap/Depr 5.27%
Cap/Sales 1.7%
Interest Coverage 250
Cash Conversion 113.81%
Profit Quality N/A
Current Ratio 1.18
Quick Ratio 1.17
Altman-Z 0.98
F-Score3
WACC5.56%
ROIC/WACC0.37
Cap/Depr(3y)8.81%
Cap/Depr(5y)10.92%
Cap/Sales(3y)3.73%
Cap/Sales(5y)3.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-207.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y-924.66%
EPS Next 2Y37.4%
EPS Next 3Y38.55%
EPS Next 5Y26.34%
Revenue 1Y (TTM)-11.78%
Revenue growth 3Y-3.68%
Revenue growth 5Y3.56%
Sales Q2Q%2.41%
Revenue Next Year-18.99%
Revenue Next 2Y-5.54%
Revenue Next 3Y-1.92%
Revenue Next 5Y3.54%
EBIT growth 1Y110.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year913.18%
EBIT Next 3Y149.4%
EBIT Next 5Y84.84%
FCF growth 1Y94.95%
FCF growth 3Y16.28%
FCF growth 5Y14.31%
OCF growth 1Y79.44%
OCF growth 3Y12.65%
OCF growth 5Y10.94%

UBISOFT ENTERTAINMENT / UBI.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for UBISOFT ENTERTAINMENT?

ChartMill assigns a fundamental rating of 3 / 10 to UBI.PA.


Can you provide the valuation status for UBISOFT ENTERTAINMENT?

ChartMill assigns a valuation rating of 3 / 10 to UBISOFT ENTERTAINMENT (UBI.PA). This can be considered as Overvalued.


What is the profitability of UBI stock?

UBISOFT ENTERTAINMENT (UBI.PA) has a profitability rating of 3 / 10.


Can you provide the financial health for UBI stock?

The financial health rating of UBISOFT ENTERTAINMENT (UBI.PA) is 4 / 10.